Cancer in systemic lupus erythematosus; a letter to the editor on current concepts

Leila Alem; Maryam Ghasemi; Sanam Saeifar; Zahra Mojtahedi; Maryam Alem

doi:10.34172/jnp.2023.21514

J Nephropathol. 2023;12(4): e21514.
doi: 10.34172/jnp.2023.21514

Scopus ID: 85172338013

Abstract View: 563

PDF Download: 191

News and Views

Cancer in systemic lupus erythematosus; a letter to the editor on current concepts

Leila Alem ¹ , Maryam Ghasemi ² , Sanam Saeifar ³ , Zahra Mojtahedi ⁴ , Maryam Alem ¹^*

¹ Nickan Research Institute, Isfahan, Iran
² Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
³ Buchmann Institute for Molecular Life Sciences (BMLS), Cluster of Excellence Frankfurt Macromolecular Complexes (CEF-MC), Goethe University Frankfurt am Main, Frankfurt am Main, Germany
⁴ School of Public Health, University of Nevada, Las Vegas, USA

*Corresponding Author: Maryam Alem, Email: drmaryamalem8@gmail.com

Keywords: Cancer, Systemic lupus erythematosus, Lupus nephritis, Meta-analysis, Malignancy, Lymphoma

Implication for health policy/practice/research/medical education:

Several investigations showed/indicated that individuals with SLE are prone to the overall malignancies.

Please cite this paper as: ALem L, Ghasemi M, Saeifar S, Mojtahedi Z, ALem M. Cancer in systemic lupus erythematosus; a letter to the editor on current concepts. J Nephropathol. 2023;12(4):e21514. DOI: 10.34172/jnp.2023.21514.